Latest Gabather News & Updates

See the latest news and media coverage for Gabather. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Gabather

Pharmaceutical company developing CNS therapeutics

gabather.com
Headquarters
Södertälje, Sweden
Founded year
2014
Company type
Public company
Number of employees
4–10
Industry
Pharmaceuticals

Last updated

Latest news about Gabather

In short: Gabather reported reduced financial losses and launched the Phase II TOTEMS study for its lead schizophrenia drug candidate, GT-002.

Company announcements

Gabather

Gabather announces GT-002 study results

Presents acute effects on psychophysiological and cognitive measures. Dated 25 November 2025. Download presentation available.

Unlock all announcements with a

Media coverage

Marketscreener

Valuation Gabather AB

Aug. 31 Gabather AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI May. 29 Gabather AB Reports Earnings...

Marketscreener

Valuation Gabather AB Deutsche Boerse AG

Aug. 31 Gabather AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI May. 29 Gabather AB Reports Earnings...

Dagens industri

Reduced losses for Gabather

Gabather, which develops drug candidates for mental illness, reports an operating result of minus 1.0 million SEK (minus 1.3) for the...

Life Science Sweden

Gabather in collaboration with Danish hospital - starts schizophrenia study

The Södertälje company Gabather will for the first time test effect on cognition in schizophrenia in patients with its most advanced drug candidate.

Unlock all articles with a

Never miss news about Gabather

Track Gabather and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Gabather competitors & trending companies

Browse news for competitors to Gabather and other trending companies.